Advertisement
Published in:
25-09-2018 | Original Paper
Morbidity related controlling of pharmaceutical expenditures using prescription data
Published in: Health and Technology | Issue 5/2018
Log inActivate our intelligent search to find suitable subject content or patents.
Select sections of text to find matching patents with Artificial Intelligence. powered by
Select sections of text to find additional relevant content using AI-assisted search. powered by
Abstract
The controlling of outpatient drug costs in Germany is implemented almost entirely on the federal state level. Each year the regional representatives of the Statutory Health Insurances (SHI) and the Association of SHI Physicians in all federal states have to define an upper limit for pharmaceutical expenditures. In the most northern federal state (Schleswig-Holstein) the regional parties agreed on a morbidity related approach solely based on prescription data to meet with the spending target. The underlying patient-related classification system is called Morbidity Related Groups (MRG). Introductory the underlying data, the present model for controlling measures and the hard-/software used today will be discussed. Subsequently improvements and extensions to the MRG classification system leading to a generalized model of drug resourcing are suggested.